[CHRS] YoY Annual Result on 31-Dec-2020 [#FY]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
25-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#FY]
Profit Trend
YoY- 47.21%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 257,244 211,042 326,551 475,824 356,071 1,556 1,556 134.18%
PBT -238,272 -291,754 -287,100 135,707 92,775 -209,409 -238,286 -0.00%
Tax -380 34,874 19,222 3,463 2,942 4,691 9,440 -
NP -237,892 -326,628 -306,322 132,244 89,833 -209,339 -238,170 -0.01%
Tax Rate - - - -2.55% -3.17% - - -
Total Cost 495,136 537,670 632,873 343,580 266,238 210,895 239,726 12.84%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -92.48 -154.77 -93.81 27.79 25.23 -13,453.66 -15,306.56 -57.30%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -2.53 -4.21 -4.06 1.85 1.29 -3.22 -4.48 -9.08%
EPS Diluted -2.53 -4.21 -4.06 1.62 1.23 -3.22 -4.48 -9.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.